14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $66.94 $83.89 Tuesday, 16th Apr 2024 AXSM stock ended at $68.81. This is 0.88% more than the trading day before Monday, 15th Apr 2024. During the day the stock fluctuated 4.40% from a day low at $67.10 to a day high of $70.05.
90 days $66.94 $98.40
52 weeks $55.03 $98.40

Historical Axsome Therapeutics prices

Date Open High Low Close Volume
2020-09-16 $81.29 $83.42 $80.77 $80.77 445 845
2020-09-15 $83.70 $84.04 $80.50 $81.26 572 598
2020-09-14 $74.40 $90.00 $74.40 $83.06 1 627 687
2020-09-11 $73.24 $75.00 $72.02 $73.03 204 591
2020-09-10 $74.93 $76.36 $73.03 $73.03 369 558
2020-09-09 $70.49 $73.29 $70.39 $72.39 469 993
2020-09-08 $66.44 $71.61 $66.15 $69.59 406 359
2020-09-04 $71.00 $71.81 $65.25 $68.34 554 316
2020-09-03 $72.53 $73.84 $69.32 $71.13 296 060
2020-09-02 $72.61 $74.12 $70.37 $73.76 525 191
2020-09-01 $73.76 $75.36 $72.41 $72.50 339 453
2020-08-31 $77.18 $77.73 $71.35 $73.31 766 620
2020-08-28 $76.32 $78.28 $76.01 $76.21 229 150
2020-08-27 $77.10 $77.20 $75.28 $76.40 202 600
2020-08-26 $78.85 $79.39 $76.02 $77.11 365 068
2020-08-25 $77.10 $79.67 $76.25 $79.31 222 140
2020-08-24 $78.00 $79.00 $75.22 $77.03 365 947
2020-08-21 $79.68 $80.26 $77.36 $77.57 423 817
2020-08-20 $79.31 $82.00 $78.75 $80.13 496 956
2020-08-19 $80.57 $80.94 $78.68 $78.95 237 521
2020-08-18 $81.60 $82.60 $79.42 $80.26 205 768
2020-08-17 $79.00 $82.29 $79.00 $81.57 269 646
2020-08-14 $79.68 $81.05 $78.46 $79.00 237 516
2020-08-13 $78.16 $80.83 $78.00 $79.76 237 426
2020-08-12 $77.79 $80.25 $77.79 $78.60 348 577
Click to get the best stock tips daily for free!

About Axsome Therapeutics

Axsome Therapeutics Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinical trial to treat Alzheimer's disease agitation, as well as that has completed phase II clinical trial ... AXSM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT